Advertisement
Kelix bio
Premium
Healthcare
09 May, 2024
Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal
Kelix Bio, an emerging markets-focused specialty generic biopharmaceutical company is looking to acquire five UAE-based pharma entities to further expand ......
Healthcare
26 March, 2024
Mubadala acquiring Afro-Indian pharma platform in landmark PE exit for DPI, others
Abu Dhabi’s sovereign investor Mubadala Investment Company, which manages assets worth $276 billion in more than 50 countries, is set ......
Advertisement
Recommended for you
Advertisement